These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10487797)

  • 21. Percutaneous coronary interventions: guidelines, short- and long-term results, and comparison with coronary artery bypass grafting.
    Cigarroa JE; Hillis LD
    Cardiol Clin; 2006 May; 24(2):255-63, vii. PubMed ID: 16781942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Target blood pressure values from the cardiologic viewpoint].
    Klein W
    Wien Med Wochenschr; 1999; 149(23-24):625-8. PubMed ID: 10721157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angina pectoris with a normal coronary angiogram.
    Yang EH; Lerman A
    Herz; 2005 Feb; 30(1):17-25. PubMed ID: 15754152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurologic injury associated with CABG surgery: outcomes, mechanisms, and opportunities for improvement.
    Likosky DS; Roth RM; Saykin AJ; Eskey CJ; Ross CS; O'Connor GT
    Heart Surg Forum; 2004; 7(6):E650-62. PubMed ID: 15769701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying the high risk patient with coronary artery disease--is ejection fraction all you need?
    Buxton AE
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S25-7. PubMed ID: 16138881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing family history of heart disease in primary care consultations: a qualitative study.
    Hall R; Saukko PM; Evans PH; Qureshi N; Humphries SE
    Fam Pract; 2007 Oct; 24(5):435-42. PubMed ID: 17728290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational prescribing of statins.
    Purcell H; Daly C; Sheppard M; Morrell J
    Practitioner; 2001 Nov; 245(1628):957-9, 962-3. PubMed ID: 11727350
    [No Abstract]   [Full Text] [Related]  

  • 30. The late open artery hypothesis--a decade later.
    Sadanandan S; Buller C; Menon V; Dzavik V; Terrin M; Thompson B; Lamas G; Hochman JS
    Am Heart J; 2001 Sep; 142(3):411-21. PubMed ID: 11526353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From the results of large trials to the optimal management of a patient].
    Onnis E; Iliceto S
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):401-4. PubMed ID: 12497943
    [No Abstract]   [Full Text] [Related]  

  • 32. TCT 2005 late-breaking trials promise to influence practice patterns.
    White J
    J Interv Cardiol; 2006 Feb; 19(1):113-6. PubMed ID: 16483351
    [No Abstract]   [Full Text] [Related]  

  • 33. Can percutaneous coronary interventions reduce death and myocardial infarction in stable and unstable coronary disease?
    Best PJ; Berger PB
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):528-36. PubMed ID: 15065151
    [No Abstract]   [Full Text] [Related]  

  • 34. Predicting the coronary risk in primary and secondary prevention. What is the difference?
    Simon J; Rosolova H
    Eur Heart J; 2001 Nov; 22(22):2047-9. PubMed ID: 11686660
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of risk factor modification through cardiac rehabilitation.
    Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
    Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The diagnosis and treatment of coronary heart disease in chronic renal failure].
    Belialov FI
    Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591
    [No Abstract]   [Full Text] [Related]  

  • 39. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
    Mayer O; Simon J; Rosolová H; De Bacquer D;
    Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to the use of statins.
    Penston J
    Br J Gen Pract; 2003 Nov; 53(496):886; author reply 887. PubMed ID: 14702911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.